Press Release Oct 14 2020

Published October 14, 2020 at 12:47 p.m. UTC

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated October 14, 2020, titled "SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of SDN-037 for the Treatment of Inflammation and Pain Associated with Ocular Surgery".

View Attachment

4:["$","main",null,{"className":"seo-shell seo-template-news","children":[["$","script",null,{"type":"application/ld+json","className":"seo-jsonld","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Press Release Oct 14 2020\",\"description\":\"Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated October 14, 2020, titled \\\"SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of SDN-037 for the Treatment of Inflammation and Pain Associated with Ocular Surgery\\\".\",\"url\":\"https://6ix.com/news/press-release-oct-14-2020-6\",\"datePublished\":\"2020-10-14T12:47:34.000Z\",\"articleSection\":\"Business\",\"about\":{\"@type\":\"Corporation\",\"name\":\"Sun Pharma Advanced Research Co. Ltd.\",\"url\":\"https://6ix.com/stock/nse-sparc/sun-pharma-advanced-research-company-limited\",\"tickerSymbol\":\"NSE:SPARC\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"6ix\",\"url\":\"https://6ix.com\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https://6ix.com/images/social-banner.png?v=2\"}}}"}}],["$","div",null,{"className":"seo-page-frame","children":[null,[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"$d"}}],["$","div",null,{"dangerouslySetInnerHTML":{"__html":"$e"}}]]]}]]}] 7:null